# Lakefront Biotherapeutics Starts New €50 Million Share Buyback

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/58124
Published: 2026-11-16T07:50:36.000Z
Updated: 2026-11-16T07:50:36.000Z
Section: Business

> The authorization took effect Nov. 16 and runs through no later than March 31, 2027. The prior €50 million program ended Oct. 16 after repurchasing about 1.99 million ordinary shares.

Lakefront Biotherapeutics NV (LKFT) began a new €50 million share repurchase authorization Nov. 16, with purchases allowed through no later than March 31, 2027, after its previous program ended.

The company completed its earlier €50 million buyback Oct. 16. That program repurchased about 1.99 million ordinary shares.


